David Wisniewski

1.9k total citations
44 papers, 1.6k citations indexed

About

David Wisniewski is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, David Wisniewski has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 17 papers in Genetics and 15 papers in Molecular Biology. Recurrent topics in David Wisniewski's work include Chronic Myeloid Leukemia Treatments (23 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Acute Myeloid Leukemia Research (8 papers). David Wisniewski is often cited by papers focused on Chronic Myeloid Leukemia Treatments (23 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Acute Myeloid Leukemia Research (8 papers). David Wisniewski collaborates with scholars based in United States, Slovakia and Switzerland. David Wisniewski's co-authors include A Strife, Bayard D. Clarkson, C Lambek, Nick Carpino, B Clarkson, Ryûji Kobayashi, Bruce Stillman, Daniel R. Marshak, Hediye Erdjument‐Bromage and W. Michael Kavanaugh and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David Wisniewski

42 papers receiving 1.6k citations

Peers

Countries citing papers authored by David Wisniewski

Since Specialization

Citations

This map shows the geographic impact of David Wisniewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wisniewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wisniewski more than expected).

Fields of papers citing papers by David Wisniewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wisniewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wisniewski. The network helps show where David Wisniewski may publish in the future.

Co-authorship network of co-authors of David Wisniewski

This figure shows the co-authorship network connecting the top 25 collaborators of David Wisniewski. A scholar is included among the top collaborators of David Wisniewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wisniewski. David Wisniewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition 2025 ·Oncogene ·David Wisniewski, Donna Voeller, Yonit A. Addissie, Sachin Kumar Deshmukh, (unknown), Maryam B. Lustberg, Darawalee Wangsa, Danny Wangsa, Kerstin Heselmeyer‐Haddad, Yoshimi Endo Greer, George W. Sledge, Stanley Lipkowitz	0
2	Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer 2023 ·Cancers ·(unknown), Yoshimi Endo Greer, David Wisniewski, (unknown), (unknown), Donna Voeller, Stanley Lipkowitz	17
3	Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth 2022 ·Journal of Biological Chemistry ·David Wisniewski, (unknown), Soumya Korrapati, Xu Zhang, (unknown), Qingrong Chen, (unknown), (unknown), Donna Voeller, Daoud Meerzaman, Udayan Guha, Natalie Porat‐Shliom, Christina M. Annunziata, Stanley Lipkowitz	5
4	Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation 2018 ·Experimental Cell Research ·David Wisniewski, Tao Ma, Abraham Schneider	19
5	Further phenotypic characterization of the primitive lineage− CD34+CD38−CD90+CD45RA− hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia 2011 ·Blood Cancer Journal ·David Wisniewski, Maurizio Affer, (unknown), B Clarkson	29
6	Quantification of change in phosphorylation of BCR‐ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells 2006 ·PROTEOMICS ·Xiquan Liang, (unknown), Darren R. Veach, David Wisniewski, Bayard D. Clarkson, Marilyn D. Resh, R. Marshall Pope	40
7	Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies 2003 ·Leukemia ·B Clarkson, A Strife, David Wisniewski, C Lambek, (unknown)	83
8	Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells. 2003 ·PubMed ·A Strife, David Wisniewski, (unknown), C Lambek, Zbigniew Darżynkiewicz, Richard T. Silver, Bayard D. Clarkson	12
9	Phosphatidylinositol 3-Kinase and Src Family Kinases Are Required for Phosphorylation and Membrane Recruitment of Dok-1 in c-Kit Signaling 2002 ·Journal of Biological Chemistry ·Xiquan Liang, David Wisniewski, A Strife, (unknown), Bayard D. Clarkson, Marilyn D. Resh	45
10	Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210BCR-ABL 2000 ·Leukemia Research ·Ellin Berman, Suresh C. Jhanwar, Mary L. McBride, A Strife, David Wisniewski, C Lambek, Bayard Clarkson	8
11	The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the Dok1 phosphoprotein in Bcr-Abl transformed cells 2000 ·Cellular Signalling ·(unknown), David Wisniewski, A Strife, Bayard Clarkson, Marilyn D. Resh	23
12	Molecular Cloning and Characterization of p56 Defines a New Family of RasGAP-binding Proteins 1998 ·Journal of Biological Chemistry ·Antonio Di Cristofano, Nick Carpino, (unknown), (unknown), Ryûji Kobayashi, A Strife, David Wisniewski, Bayard D. Clarkson, Pier Paolo Pandolfi, Marilyn D. Resh	114
13	New understanding of the pathogenesis of CML: a prototype of early neoplasia 1997 ·Leukemia ·(unknown), A Strife, David Wisniewski, C Lambek, Nick Carpino	59
14	c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells. 1996 ·PubMed ·David Wisniewski, A Strife, B Clarkson	32
15	Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand 1993 ·Leukemia Research ·A Strife, (unknown), C Lambek, David Wisniewski, Silvia Bruno, Zbigniew Darżynkiewicz, Bayard D. Clarkson	10
16	Integration of Molecular and Biological Abnormalities in Quest for Selective Treatment of Chronic Myelogenous Leukemia (CML) 1993 ·Leukemia & lymphoma ·B Clarkson, A Strife, Alexendar R. Perez, C Lambek, David Wisniewski	6
17	Constitutive expression of p53 protein in enriched normal human marrow blast cell populations [see comments] 1992 ·Blood ·(unknown), David Wisniewski, A Strife, Alexendar R. Perez, C Lambek, Stefania Bruno, Zbigniew Darżynkiewicz, B Clarkson	29
18	Co-detection of chimeric bcr/abl (target) and β-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction 1991 ·Leukemia Research ·David Wisniewski, A Strife, Bayard D. Clarkson	7
19	Induction of Nonspecific Cell-Mediated Cytotoxicity: A Multisignal Event and its Cellular Regulation 1989 ·Hämatologie und Bluttransfusion ·Jens Atzpodien, Christoph Bührer, Subhash C. Gulati, David Wisniewski, (unknown), H. Kirchner, T. Benter, H. Poliwoda, Karl Welte, B Clarkson	1
20	Cell-Mediated Toxicity of Interleukin-2-Activated Lymphocytes against Autologous and Allogeneic Human Myeloma Cells 1988 ·Acta Haematologica ·Chihiro Shimazaki, Jens Atzpodien, David Wisniewski, Subhash C. Gulati, Jonathan E. Kolitz, Jerrold Fried, Bayard D. Clarkson	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact